People who drank five or more cups of coffee a day had about a 32% lower risk of cirrhosis than a comparison group, according to a study using data from roughly 354,000 UK Biobank participants. The study found an association; it did not establish that coffee caused the lower risk.

The research by Kim Hyun-Seok and colleagues, published in Clinical Gastroenterology and Hepatology in 2026, compared coffee-drinking habits with the occurrence of liver disease over an average of 13 years. Some participants also underwent liver MRI scans and blood protein tests.

Among those drinking at least five cups daily, the risk of liver cancer was 47% lower and the risk of death from liver disease was 42% lower. The pattern appeared in people who drank either caffeinated or decaffeinated coffee.

People who added sugar or other sweeteners also showed a lower risk of liver disease. Sweetener use, however, was associated with a slight increase in an MRI marker reflecting problems in liver tissue. The finding raises a question about what drinkers add to their coffee.

Citing WebMD, CNN Indonesia reported that coffee contains more than 1,000 chemicals besides caffeine. Paraxanthine, produced when the body breaks down caffeine, may slow the formation of scar tissue. Two other compounds, kahweol and cafestol, have been suggested to have cancer-fighting properties, although the strength of their effects remains unclear. The report also described a potential role for moderate amounts of unsweetened coffee alongside primary treatment for hepatocellular carcinoma.